MATERAZZI, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 14.769
EU - Europa 7.755
AS - Asia 2.332
AF - Africa 341
SA - Sud America 44
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 25.251
Nazione #
US - Stati Uniti d'America 14.413
IT - Italia 3.498
SE - Svezia 1.263
CN - Cina 1.098
DE - Germania 1.036
BG - Bulgaria 654
SG - Singapore 474
GB - Regno Unito 354
CA - Canada 350
TR - Turchia 272
VN - Vietnam 262
CI - Costa d'Avorio 202
FI - Finlandia 202
AT - Austria 187
UA - Ucraina 179
IN - India 97
SN - Senegal 95
RU - Federazione Russa 94
CH - Svizzera 82
HK - Hong Kong 73
FR - Francia 69
BE - Belgio 35
NG - Nigeria 31
BR - Brasile 25
NL - Olanda 22
CZ - Repubblica Ceca 16
ES - Italia 13
IR - Iran 12
PL - Polonia 9
KR - Corea 8
CL - Cile 7
RO - Romania 7
GR - Grecia 6
ID - Indonesia 6
JP - Giappone 6
AU - Australia 5
BJ - Benin 5
HU - Ungheria 5
IE - Irlanda 5
CO - Colombia 4
TW - Taiwan 4
DK - Danimarca 3
EU - Europa 3
IL - Israele 3
MX - Messico 3
PT - Portogallo 3
PY - Paraguay 3
RS - Serbia 3
EC - Ecuador 2
EE - Estonia 2
EG - Egitto 2
IQ - Iraq 2
JO - Giordania 2
KZ - Kazakistan 2
MA - Marocco 2
PE - Perù 2
PK - Pakistan 2
SV - El Salvador 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 25.251
Città #
Woodbridge 1.786
Fairfield 1.750
Houston 1.266
Chandler 1.257
Ann Arbor 1.220
Ashburn 951
Seattle 706
Milan 662
Sofia 646
Wilmington 606
Cambridge 604
New York 427
Beijing 408
Serra 401
Ottawa 333
Boardman 319
Princeton 300
Lawrence 261
Izmir 252
Jacksonville 249
Medford 224
Abidjan 202
Nanjing 198
Florence 186
Vienna 178
Singapore 169
Des Moines 152
Pisa 141
Rome 141
Dong Ket 132
Dearborn 111
San Diego 100
Dakar 95
London 76
Bern 72
Frankfurt am Main 72
Hong Kong 68
Bremen 66
Nanchang 62
Ogden 61
Redwood City 56
Lancaster 52
Kunming 51
Jüchen 47
Hebei 44
Los Angeles 43
Boulder 42
Naples 41
Changsha 35
Falls Church 35
Shenyang 33
Bologna 31
Brussels 31
Lagos 30
Norwalk 30
Hefei 28
Washington 28
Jiaxing 27
Shanghai 27
Tianjin 27
Dallas 24
Marseille 22
Pune 22
Nürnberg 20
Guangzhou 19
Lucca 18
Phoenix 18
Rho 18
San Francisco 18
Hangzhou 16
Vicopisano 16
Chicago 15
Livorno 15
Massa 15
Turin 15
Cagliari 14
Düsseldorf 14
Jinan 14
Napoli 14
Pontedera 14
Redmond 14
Verona 14
Hyderabad 13
Kent 13
Grafing 12
Indiana 12
Munich 12
Palermo 12
Auburn Hills 11
Bari 11
Brno 11
Jaboatão 11
Messina 11
Parma 11
Trieste 11
Zhengzhou 11
Catania 10
Lanzhou 10
Toronto 10
Amsterdam 9
Totale 18.218
Nome #
I CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE HANNO ORIGINE GENETICA INDIPENDENTE 806
Fistole del seno piriforme in un adolescente 771
Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy 259
L’ANALISI GENETICA DI CARCINOMI PAPILLARI E MIDOLLARI DELLA TIROIDE PRESENTI CONTEMPORANEAMENTE RIVELA LA LORO NATURA CASUALE 254
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland 167
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 161
null 160
Acquired Carotid-Jugular Fistula: Its Changing History and Management 160
Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology? 159
Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction. 159
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 159
Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro 158
null 157
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo 155
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study 152
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 144
Video-assisted thyroidectomy: indications and results 143
Minimally invasive video-assisted thyroidectomy (MIVAT) from A to Z 143
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo 141
Modified lateral neck lymphadenectomy: prospective randomized study comparing harmonic scalpel with clamp-and-tie technique 140
Evaluation of a new ultrasonic device in thyroid surgery: comparative randomized study 138
Minimally invasive video-assisted thyroidectomy: reflections after more than 2400 cases performed. 138
Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med. 2002 Nov;10(5):589-92 136
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 136
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 135
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 133
Sorafenib and Thyroid Cancer 132
CCL2 is Modulated by Cytokines and PPAR-g in Anaplastic Thyroid Cancer 131
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 131
Conservative management of a tracheal leakage occurring 40 days after robotic thyroidectomy 130
Endoscopic Parathyroidectomy 129
Silent Pheocromocytoma presenting as tako-Tsubo syndrom during anesthesiological stress. 129
Minimally Invasive Videoassisted thyroidectomy 129
Aggressive thyroid cancer: targeted therapy with sorafenib 129
Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: A prospective randomized trial 127
Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures. 127
Indeterminate Single Thyroid Nodule: Synergistic Impact of Mutational Markers and Sonographic Features in Triaging Patients to Appropriate Surgery. 126
No outcome differences between a laparoscopic and retroperitoneoscopic approach in synchronous bilateral adrenal surgery. 124
Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: A prospective randomized trial 124
Cabozantinib in Thyroid Cancer 124
A reappraisal of the indications for laparoscopic treatment of adrenal metastases 123
null 122
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo 122
BRAFV600E mutation: a potential predictor of more than a Sistrunk's procedure in patients with thyroglossal duct cyst carcinoma and a normal thyroid gland 122
A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases 121
Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update 119
Sorafenib in the treatment of thyroid cancer 119
The extent of surgery in thyroglossal cyst carcinoma 118
Primary cell cultures from anaplastic thyroid cancer obtained by fine-needle aspiration used for chemosensitivity tests 118
The necessity for a thoracic approach in thyroid surgery 117
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 117
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 116
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 115
Cosmetic result and overall satisfaction after minimally invasive video-assisted thyroidectomy (MIVAT) versus robot-assisted transaxillary thyroidectomy (RATT): A prospective randomized study 115
ANTIGENIC EXPRESSION OF M2 PYRUVATE-KINASE IN COLON RECTAL CANCER.PRELIMINARY RESULTS OF AN IMMUNOISTCHEMICAL STUDY 114
Track Recurrence after Robotic Transaxillary Thyroidectomy: A Case Report Highlighting the Importance of Controlled Surgical Indications and Addressing Unprecedented Complications 114
Postoperative Pain Evaluation After Robotic Transaxillary Thyroidectomy Versus Conventional Thyroidectomy: A Prospective Study 113
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 113
The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis 112
Minimally invasive, video-assisted thyroidectomy (MIVAT) 111
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 111
Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis 110
Letter 1: Focused parathyroid surgery with intraoperative parathyroid hormone measurement as a day-case procedure (Br J Surg 2004; 91: 78-82) 109
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 109
The Role of Total Thyroidectomy in the Initial Treatment of Well-differentiated Follicular-cell-derived Thyroid Carcinomas 109
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas 108
Evaluation of a preoperative pain score in response to pressure as a marker of postoperative pain and drugs consumption in surgical thyroidectomy. 107
Radiofrequency Ablation in the Treatment of Benign Thyroid Nodules: An Efficient and Safe Alternative to Surgery 107
Analysis of circulating tumor DNA does not improve the clinical management of patients with locally advanced and metastatic papillary thyroid carcinoma 107
EVIDENCE OF A LOW PREVALENCE OF RAS MUTATIONS IN A LARGE MEDULLARY THYROID CANCER SERIES 106
E-selectin expression and BRAF status in papillary thyroid carcinomas: Correlation with clinicopathologic features 106
Peduncolated adenomas with invasive carcinoma removed endoscopically . Is it necessary surgical treatment? 105
Extensive clinical experience - Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma 105
No outcome differences between a laparoscopic and retroperitoneoscopic approach in synchronous bilateral adrenal surgery. 105
Minimally invasive approach to the cervical spine: a proposal 105
CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation 105
Tyrosine Kinase Inhibitors; Therapies for Thyroid Cancer 105
Metachronous adrenal masses in resected non-small cell lung cancer patients:therapeutic implications of laparoscopic adrenalectomy 105
Minimally Invasive Video-Assisted Parathyroidectomy: Lesson Learned from 137 cases 104
New insights in the molecular signature of advanced medullary thyroid cancer: Evidence of a bad outcome of cases with double RET mutations 104
Clinical profile of juvenile primary hyperparathyroidism: a prospective study 104
Combination of mini-invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders 103
Differences in miRNA expression profiles between wild-type and mutated NIFTPs 103
Impact of harmonic scalpel on operative time during video-assisted thyroidectomy 103
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 103
Dedifferentiated thyroid cancer: a therapeutic challenge 102
Advantages and disadvantages of prophylactic central compartment lymph node dissection for differentiated thyroid cancer: the first randomized controlled study from a single referral center. 102
Novel treatment options for anaplastic thyroid cancer 102
Central Neck Dissection Cannot Be Avoided In Medullary Thyroid Cancer (MTC) On The Basis Of Presurgical Serum Calcitonin (CT) 102
Minimally invasive video-assisted thyroidectomy for papillary carcinoma: a prospective study of its completeness 101
Results of video-assisted parathyroidectomy: single institution's six-year experience 101
Minimally Invasive Videoassisted Thyroidectomy 100
Minimally invasive video-assisted thyroidectomy 100
Minimally invasive thyroidectomy in the treatment of well differentiated thyroid cancers: indications and limits 100
Papillary Thyroid Carcinoma With Rare exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience 100
A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma 100
Video-assisted central compartment lymphadenectomy in a patient with a positive RET oncogene: initial experience 100
null 99
null 99
Selective use of vandetanib in the treatment of thyroid cancer 99
Totale 13.652
Categoria #
all - tutte 72.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.834


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.981 0 0 419 282 453 486 532 383 564 350 393 119
2020/20212.145 226 129 130 81 175 137 189 199 203 185 148 343
2021/20223.013 75 144 101 184 557 440 73 137 169 82 179 872
2022/20234.121 478 536 282 346 439 492 61 331 726 48 306 76
2023/20243.406 355 316 382 297 466 552 190 134 106 87 195 326
2024/2025594 135 379 80 0 0 0 0 0 0 0 0 0
Totale 25.817